HC Wainwright & Co. Reiterates Buy Rating on FibroBiologics, Inc. Common Stock (FBLG)

Market Context

FibroBiologics, Inc. Common Stock operates in the Healthcare sector. The stock currently trades at $0.82 with a market capitalization of $14.4M.

Analyst coverage from HC Wainwright & Co. provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for FibroBiologics, Inc. Common Stock.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for FibroBiologics, Inc. Common Stock

Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Aug 04, 2026	HC Wainwright & Co.	Buy	N/A
May 04, 2026	Maxim Group	Hold	N/A
Apr 16, 2026	HC Wainwright & Co.	Buy	N/A
Mar 26, 2026	D. Boral Capital	Hold	N/A
Mar 12, 2026	D. Boral Capital	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View FBLG Stock Page